Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Lipid Catabolism01:25

Lipid Catabolism

Triglycerides serve as crucial long-term energy storage molecules in microorganisms, providing a dense source of metabolic energy. Their breakdown is mediated by lipases, which hydrolyze triglycerides into glycerol and free fatty acids. Each of these components follows distinct metabolic pathways, ultimately contributing to ATP synthesis and cellular energy homeostasis.Glycerol MetabolismGlycerol, released from triglyceride hydrolysis, is phosphorylated by glycerol kinase to form...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Clinical and HIV Surveillance Data to Determine Care Status for People With HIV in Washington, DC.

Journal of acquired immune deficiency syndromes (1999)·2026
Same author

Exploring Intersectionality Among Latinos Living with HIV: A CHAID Analysis of Health Outcomes and Care Engagement.

Journal of racial and ethnic health disparities·2026
Same author

Characterizing STI testing and diagnosis disparities between Asian people with HIV and other racial/ethnic subpopulations in Washington, District of Columbia: a longitudinal analysis of the DC Cohort, 2018-2023.

Sexual health·2025
Same author

Prevalence, incidence, and risk factors for dermatologic conditions in people with HIV in the modern antiretroviral era: A cohort study in Washington, DC.

Journal of the American Academy of Dermatology·2025
Same author

Integration of Patient Reported Outcomes Data among People with HIV in Washington, DC: A sub-cohort of the DC Cohort Longitudinal Study.

Journal of public health (Berlin, Germany)·2025
Same author

Prevalence and risk factors for post-COVID conditions of COVID-19 among persons with HIV in Washington, DC.

AIDS care·2024

Related Experiment Video

Updated: Jul 9, 2026

Encapsulation Thermogenic Preadipocytes for Transplantation into Adipose Tissue Depots
08:30

Encapsulation Thermogenic Preadipocytes for Transplantation into Adipose Tissue Depots

Published on: June 2, 2015

TH9507: an experimental treatment for lipodystrophy.

Anne Monroe

    BETA : Bulletin of Experimental Treatments for AIDS : a Publication of the San Francisco AIDS Foundation
    |December 12, 2007
    PubMed
    Summary

    Highly active antiretroviral therapy (HAART) can cause lipodystrophy syndrome in HIV patients, characterized by body fat changes and metabolic issues. A new drug, TH9507, shows promise for treating this condition.

    Area of Science:

    • Endocrinology
    • Virology
    • Metabolic Medicine

    Background:

    • Highly active antiretroviral therapy (HAART) for HIV has been associated with lipodystrophy syndrome.
    • This syndrome involves abnormal body fat distribution and metabolic complications like insulin resistance.

    Discussion:

    • Current treatment options for lipodystrophy are limited.
    • Growth hormone has demonstrated efficacy in reducing visceral adipose tissue in clinical trials.
    • TH9507, a novel synthetic growth hormone-releasing hormone analog, is emerging as a potential therapeutic agent.

    Key Insights:

    • Lipodystrophy syndrome presents a significant challenge for individuals on HAART.
    • TH9507 offers a promising new avenue for managing fat redistribution and metabolic disturbances.

    More Related Videos

    Custom-designed Laser-based Heating Apparatus for Triggered Release of Cisplatin from Thermosensitive Liposomes with Magnetic Resonance Image Guidance
    07:47

    Custom-designed Laser-based Heating Apparatus for Triggered Release of Cisplatin from Thermosensitive Liposomes with Magnetic Resonance Image Guidance

    Published on: December 13, 2015

    Related Experiment Videos

    Last Updated: Jul 9, 2026

    Encapsulation Thermogenic Preadipocytes for Transplantation into Adipose Tissue Depots
    08:30

    Encapsulation Thermogenic Preadipocytes for Transplantation into Adipose Tissue Depots

    Published on: June 2, 2015

    Custom-designed Laser-based Heating Apparatus for Triggered Release of Cisplatin from Thermosensitive Liposomes with Magnetic Resonance Image Guidance
    07:47

    Custom-designed Laser-based Heating Apparatus for Triggered Release of Cisplatin from Thermosensitive Liposomes with Magnetic Resonance Image Guidance

    Published on: December 13, 2015

  • Clinical trials indicate positive outcomes for TH9507 in treating specific lipodystrophy types.

    • Outlook:

    • Further research and clinical trials are essential to establish TH9507's long-term safety and efficacy.
    • TH9507 may expand treatment options for HIV-associated lipodystrophy.
    • This analog could potentially improve the quality of life for affected patients.